FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090841339> ?p ?o ?g. }

• W2090841339 endingPage "150" @default.
• W2090841339 startingPage "143" @default.
• W2090841339 abstract "Medulloblastoma is a heterogeneous diffuse neoplasm that can be highly disseminated, and is the most common malignant childhood brain tumor. Although multimodal treatments have improved survival rates for patients with medulloblastoma, these tumors are associated with high morbidity and mortality. New treatment strategies are urgently needed to improve cure rates and, importantly, to spare normal brain tissue from neurotoxicity and patients from life-long cognitive and functional deficits associated with current therapies. In numerous preclinical brain tumor models, neural stem cells (NSCs) have shown great promise as delivery vehicles for therapeutic genes. Here, we have used an established, genetically modified human NSC line (HB1.F3.CD) to deliver carboxylesterase (CE) to cerebellar tumor foci and locally activate the prodrug camptothecin-11 (CPT-11) (Irinotecan) to the potent topoisomerase I inhibitor SN-38. HB1.F3.CD NSC tumor tropism, intratumoral distribution and therapeutic efficacy were investigated in clinically relevant experimental models. Magnetic resonance imaging was used for in vivo tracking of iron nanoparticle-labeled NSCs, and to assess the therapeutic efficacy of CE-expressing HB1.F3.CD cells. As compared with controls, a significant decrease in tumor growth rate was seen in mice that received both NSCs and CPT-11 as their treatment regimen. Thus, this study provides proof-of-concept for NSC-mediated CE/CPT-11 treatment of medulloblastoma, and serves as a foundation for further studies toward potential clinical application." @default.
• W2090841339 created "2016-06-24" @default.
• W2090841339 creator A5004710918 @default.
• W2090841339 creator A5014173403 @default.
• W2090841339 creator A5018750805 @default.
• W2090841339 creator A5021389782 @default.
• W2090841339 creator A5032312549 @default.
• W2090841339 creator A5033597074 @default.
• W2090841339 creator A5038297827 @default.
• W2090841339 creator A5038864663 @default.
• W2090841339 creator A5041131679 @default.
• W2090841339 creator A5047195770 @default.
• W2090841339 creator A5050669914 @default.
• W2090841339 creator A5061976329 @default.
• W2090841339 creator A5067044478 @default.
• W2090841339 creator A5067219287 @default.
• W2090841339 creator A5068645990 @default.
• W2090841339 creator A5081967247 @default.
• W2090841339 date "2012-03-08" @default.
• W2090841339 modified "2023-10-18" @default.
• W2090841339 title "Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma" @default.
• W2090841339 cites W142203824 @default.
• W2090841339 cites W1505550085 @default.
• W2090841339 cites W1936342032 @default.
• W2090841339 cites W1971412744 @default.
• W2090841339 cites W1977934887 @default.
• W2090841339 cites W1980441719 @default.
• W2090841339 cites W1990900025 @default.
• W2090841339 cites W1992848513 @default.
• W2090841339 cites W2004341342 @default.
• W2090841339 cites W2005348472 @default.
• W2090841339 cites W2012211657 @default.
• W2090841339 cites W2038037578 @default.
• W2090841339 cites W2040293283 @default.
• W2090841339 cites W2044952801 @default.
• W2090841339 cites W2054139397 @default.
• W2090841339 cites W2054235928 @default.
• W2090841339 cites W2066301243 @default.
• W2090841339 cites W2067839238 @default.
• W2090841339 cites W2075862824 @default.
• W2090841339 cites W2097196308 @default.
• W2090841339 cites W2099886521 @default.
• W2090841339 cites W2102698959 @default.
• W2090841339 cites W2117049363 @default.
• W2090841339 cites W2119242698 @default.
• W2090841339 cites W2120173083 @default.
• W2090841339 cites W2121699071 @default.
• W2090841339 cites W2126863379 @default.
• W2090841339 cites W2127771136 @default.
• W2090841339 cites W2129461451 @default.
• W2090841339 cites W2134678701 @default.
• W2090841339 cites W2135212691 @default.
• W2090841339 cites W2146274229 @default.
• W2090841339 cites W2147684739 @default.
• W2090841339 cites W2148278891 @default.
• W2090841339 cites W2165551601 @default.
• W2090841339 cites W2167454336 @default.
• W2090841339 cites W4206439534 @default.
• W2090841339 doi "https://doi.org/10.1038/gt.2012.12" @default.
• W2090841339 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4149468" @default.
• W2090841339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22402322" @default.
• W2090841339 hasPublicationYear "2012" @default.
• W2090841339 type Work @default.
• W2090841339 sameAs 2090841339 @default.
• W2090841339 citedByCount "39" @default.
• W2090841339 countsByYear W20908413392012 @default.
• W2090841339 countsByYear W20908413392013 @default.
• W2090841339 countsByYear W20908413392014 @default.
• W2090841339 countsByYear W20908413392015 @default.
• W2090841339 countsByYear W20908413392016 @default.
• W2090841339 countsByYear W20908413392017 @default.
• W2090841339 countsByYear W20908413392018 @default.
• W2090841339 countsByYear W20908413392019 @default.
• W2090841339 countsByYear W20908413392021 @default.
• W2090841339 countsByYear W20908413392022 @default.
• W2090841339 countsByYear W20908413392023 @default.
• W2090841339 crossrefType "journal-article" @default.
• W2090841339 hasAuthorship W2090841339A5004710918 @default.
• W2090841339 hasAuthorship W2090841339A5014173403 @default.
• W2090841339 hasAuthorship W2090841339A5018750805 @default.
• W2090841339 hasAuthorship W2090841339A5021389782 @default.
• W2090841339 hasAuthorship W2090841339A5032312549 @default.
• W2090841339 hasAuthorship W2090841339A5033597074 @default.
• W2090841339 hasAuthorship W2090841339A5038297827 @default.
• W2090841339 hasAuthorship W2090841339A5038864663 @default.
• W2090841339 hasAuthorship W2090841339A5041131679 @default.
• W2090841339 hasAuthorship W2090841339A5047195770 @default.
• W2090841339 hasAuthorship W2090841339A5050669914 @default.
• W2090841339 hasAuthorship W2090841339A5061976329 @default.
• W2090841339 hasAuthorship W2090841339A5067044478 @default.
• W2090841339 hasAuthorship W2090841339A5067219287 @default.
• W2090841339 hasAuthorship W2090841339A5068645990 @default.
• W2090841339 hasAuthorship W2090841339A5081967247 @default.
• W2090841339 hasBestOaLocation W20908413391 @default.
• W2090841339 hasConcept C104317684 @default.
• W2090841339 hasConcept C108215921 @default.
• W2090841339 hasConcept C111599444 @default.
• W2090841339 hasConcept C121608353 @default.

• next